查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529789

全球個人化醫療外包市場：市場規模、佔有率、趨勢分析 - 按階段、按應用、按服務、按類型、按最終用途、按地區、細分市場預測，2024-2030 年

Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Clinical, Preclinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

預計2023年全球個人化醫療外包市場規模將達1,016.2億美元，2024年至2030年複合年成長率為12.21%。

人們對個人化醫療益處的認知不斷提高，個人化醫療在罕見疾病、癌症和感染疾病，對專業知識的需求以及外包服務的好處這些是推動市場的主要因素。生長。

慢性病、罕見疾病和感染疾病的盛行率不斷上升，進一步增加了對這些藥物的需求，以改善患者的治療效果。美國癌症協會公佈的資料顯示，2023年美國將有約609,820人死於癌症。

個人化醫療在癌症治療的應用顯著增加，這是市場成長的關鍵驅動力之一。個人化醫療或精準醫療在腫瘤學中有多種用途，包括早期檢測某些癌症、識別癌症高風險族群、評估治療方案以及治療對患者健康的影響。隨著此類疾病負擔的增加，對個人化醫療的需求也預計會增加。

此外，隨著許多製藥公司選擇將藥物開發和製造活動委託給這些外包公司，CRO 和 CDMO 在過去幾年中經歷了顯著成長。建立和維護個人化醫療從開發到製造各個方面的內部能力需要多種資源和投資。因此，外包這些活動為公司提供了根據其需求量身定做的專業知識、基礎設施和資源，使他們能夠提供具有成本效益的解決方案。此外，與開發個人化解決方案相關的複雜性和風險（例如臨床前和臨床階段的失敗）是重要的風險因素，而 CRO 可以處理複雜的後期開發和製造，使公司業務簡化流程並提高效率。

近年來，個人化醫療因其多種好處而獲得了廣泛認可，包括減少試驗錯、幫助避免副作用以及將醫學重點從預防轉向應對。個人化醫療提供了使用分子標記的能力，甚至可以在臨床症狀或體徵出現之前指示疾病的風險或存在，從而可以及早治療疾病，從而改善患者的治療效果。

同樣，患者不遵守所提供的治療或藥物可能會導致藥物不良反應 (ADR) 等負面健康影響。因此，ADR病例的增加將增加人口對更好治療選擇的需求，進一步增加對個人化醫療的需求。例如，根據美國國立衛生美國（NIH）2024年1月發表的論文，2022年美國將出現約125萬例嚴重副作用病例，約17.5萬人死亡。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章個人化醫療外包市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
  • 市場分析工具

第4章個人化醫療外包市場：逐步估算與趨勢分析

  • 細分儀表板
  • 全球個人化醫療外包市場相變分析
  • 2018-2030年全球個人化醫療外包市場規模及趨勢分析（分階段）
  • 臨床
  • 臨床前

第5章個人化醫療外包市場：應用預估與趨勢分析

  • 細分儀表板
  • 全球個人化醫療外包市場應用變遷分析
  • 2018-2030年全球個人化醫療外包市場規模及趨勢分析（按應用）
  • 腫瘤學
  • 罕見疾病
  • 感染疾病
  • 其他

第6章個人化醫療外包市場：服務評估與趨勢分析

  • 細分儀表板
  • 全球個人化醫療外包市場服務波動分析
  • 2018-2030年全球個人化醫療外包市場規模及趨勢分析（按服務）
  • 契約製造
  • 合約開發

第7章個人化醫療外包市場：類型估算與趨勢分析

  • 細分儀表板
  • 全球個人化醫療外包市場類型變異分析
  • 2018-2030年全球個人化醫療外包市場規模及趨勢分析（按類型）
  • 抑制劑
  • 單株抗體
  • 細胞/基因治療
  • 其他

第8章個人化醫療外包市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 全球個人化醫療外包市場的最終用途變化分析
  • 2018-2030年全球個人化醫療外包市場規模及趨勢分析（依最終用途）
  • 製藥公司
  • 生技公司
  • 其他

第9章個人化醫療外包市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 2018-2030 年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030 年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • Parexel International（MA）Corporation
    • Syneos Health
    • Catalent, Inc
    • ICON
    • Lonza
    • Syngene International Limited
    • HCL Technologies Limited
    • Infosys Limited
    • Fujirebio
    • Aurigene Pharmaceutical Services Ltd.
Product Code: GVR-4-68040-350-7

Market Size & Trends

The global personalized medicine outsourcing market size was estimated at USD 101.62 billion in 2023 and is projected to grow at a CAGR of 12.21% from 2024 to 2030. The increasing awareness about the benefits of personalized medicine, increasing application of personalized medicine in various diseases, such as rare diseases, cancer, infectious diseases, and others, the requirement of specialized expertise, and the benefits of outsourcing the services are some of the major factors driving the market growth.

The increasing prevalence of diseases such as chronic diseases, rare diseases and infectious diseases is further increasing the demand for these medicines as it offers enhanced patient outcomes. According to the data published by American Cancer Society, cancer was expected to cause around 609,820 deaths in the U.S. in 2023 and was expected to diagnose over 1.9 people in the same year.

The applications of personalized medicine have significantly increased in cancer care, which is one of the major factors contributing to the market growth. Personalized medicine or precision medicine is utilized for several purposes in oncology such as early detection of certain cancers, identifying people with higher cancer risk, evaluation of treatment alternatives, and effect of treatment on patient's health. As the burden of these diseases increase, the demand for personalized medicine is also anticipated to witness growth.

Furthermore, CROs and CDMOs have witnessed significant growth during the past few years as most of the pharmaceutical companies are opting to outsource their drug development and manufacturing activities to these outsourcing companies. Building and maintaining internal capabilities for all aspects of personalized medicine, from development to manufacturing, requires several resources and investments. Therefore, outsourcing these activities can allow companies to access specialized expertise, infrastructure, and resources according to their needs, thereby offering a cost-effective solution. Moreover, the complexity and risk associated with the development of personalized solutions, such as failures in the preclinical and clinical phases, offer a significant risk factor, while CROs can handle the complexities of later-stage development and manufacturing, allowing companies to streamline their operations and enhance their efficiency.

The awareness about personalized medicine has significantly increased in recent years owing to its several benefits, such as reducing trial and error prescribing, helping in avoiding adverse drug reactions, and shifting the medical emphasis from prevention to reaction. Personalized medicine offers the ability to use molecular markers that can indicate the disease risk or presence even before clinical signs and symptoms appear, allowing for early treatments of diseases and thereby improving patient outcomes.

Similarly, the patient's non-compliance with offered treatment and medication can lead to adverse health effects such as Adverse Drug Reactions (ADR), which have been on a significant rise in past years. Thus, increasing cases of ADRs would boost the demand for better treatment options among people further driving the demand for personalized medicine. For instance, according to an article published by the National Institute of Health (NIH) in January 2024, there were around 1.25 million serious adverse effects and approximately 175,000 deaths were recorded in the U.S. in 2022.

Global Personalized Medicine Outsourcing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global personalized medicine outsourcing market report based on phase, application, service, type, end-use, and region.

  • Phase Outlook (Revenue, USD Million, 2018 - 2030)
  • Clinical

Phase I

Phase II

Phase III

Phase IV

  • Preclinical
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology
  • Rare Diseases
  • Infectious Diseases
  • Others
  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Contract Manufacturing
  • Contact Development
  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Inhibitor Drugs
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Other Therapeutic Products
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Mexico

Argentina

  • MEA

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Phase Segment
    • 1.2.2. Application Segment
    • 1.2.3. Service Segment
    • 1.2.4. Type Segment
    • 1.2.5. End use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Personalized Medicine Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic and rare diseases
      • 3.2.1.2. Increasing awareness about the benefits of personalized medicine
      • 3.2.1.3. Increasing application of personalized medicine in various diseases
      • 3.2.1.4. Requirement of specialized expertise for personalized medicine development and manufacturing
    • 3.2.2. Market restraints analysis
      • 3.2.2.1. Data Privacy Concerns
  • 3.3. Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Personalized Medicine Outsourcing Market: Phase Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Personalized Medicine Outsourcing Market Phase Movement Analysis
  • 4.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Phase, 2018 to 2030 (USD Million)
  • 4.4. Clinical
    • 4.4.1. Clinical market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Phase I
      • 4.4.2.1. Phase I market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Phase II
      • 4.4.3.1. Phase II market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Phase III
      • 4.4.4.1. Phase III market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Phase IV
      • 4.4.5.1. Phase IV market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Preclinical
    • 4.5.1. Preclinical market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Personalized Medicine Outsourcing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Personalized Medicine Outsourcing Market Application Movement Analysis
  • 5.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Rare Diseases
    • 5.5.1. Rare Diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Infectious Diseases
    • 5.6.1. Infectious Diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Personalized Medicine Outsourcing Market: Service Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Personalized Medicine Outsourcing Market Service Movement Analysis
  • 6.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 6.4. Contract Manufacturing
    • 6.4.1. Contract Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Contact Development
    • 6.5.1. Contact Development market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Personalized Medicine Outsourcing Market: Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Personalized Medicine Outsourcing Market Type Movement Analysis
  • 7.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 7.4. Inhibitor Drugs
    • 7.4.1. Inhibitor Drugs market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Monoclonal Antibodies
    • 7.5.1. Monoclonal Antibodies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Cell & Gene Therapy
    • 7.6.1. Cell & Gene Therapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Personalized Medicine Outsourcing Market: End use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Personalized Medicine Outsourcing Market End use Movement Analysis
  • 8.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical Companies
    • 8.4.1. Pharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Biotechnology Companies
    • 8.5.1. Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Personalized Medicine Outsourcing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Target disease prevalence
      • 9.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Target disease prevalence
      • 9.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Target disease prevalence
      • 9.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Target disease prevalence
      • 9.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Target disease prevalence
      • 9.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Target disease prevalence
      • 9.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Target disease prevalence
      • 9.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Target disease prevalence
      • 9.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Competitive scenario
      • 9.5.7.3. Regulatory framework
      • 9.5.7.4. Target disease prevalence
      • 9.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Competitive scenario
      • 9.5.8.3. Regulatory framework
      • 9.5.8.4. Target disease prevalence
      • 9.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.9. Denmark
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Competitive scenario
      • 9.5.9.3. Regulatory framework
      • 9.5.9.4. Target disease prevalence
      • 9.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Target disease prevalence
      • 9.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Competitive scenario
      • 9.6.3.3. Regulatory framework
      • 9.6.3.4. Target disease prevalence
      • 9.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Competitive scenario
      • 9.6.4.3. Regulatory framework
      • 9.6.4.4. Target disease prevalence
      • 9.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Competitive scenario
      • 9.6.5.3. Regulatory framework
      • 9.6.5.4. Target disease prevalence
      • 9.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Competitive scenario
      • 9.6.6.3. Regulatory framework
      • 9.6.6.4. Target disease prevalence
      • 9.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Competitive scenario
      • 9.6.7.3. Target disease prevalence
      • 9.6.7.4. Regulatory framework
      • 9.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Target disease prevalence
      • 9.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Target disease prevalence
      • 9.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Competitive scenario
      • 9.8.2.3. Regulatory framework
      • 9.8.2.4. Target disease prevalence
      • 9.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Competitive scenario
      • 9.8.3.3. Regulatory framework
      • 9.8.3.4. Target disease prevalence
      • 9.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Competitive scenario
      • 9.8.4.3. Regulatory framework
      • 9.8.4.4. Target disease prevalence
      • 9.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Competitive scenario
      • 9.8.5.3. Regulatory framework
      • 9.8.5.4. Target disease prevalence
      • 9.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2023
  • 10.4. Company Profiles/Listing
    • 10.4.1. Parexel International (MA) Corporation
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Syneos Health
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Catalent, Inc
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. ICON
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Lonza
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Syngene International Limited
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. HCL Technologies Limited
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Infosys Limited
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Fujirebio
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Aurigene Pharmaceutical Services Ltd.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global personalized medicine outsourcing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 4 Global personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 6 Global personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 7 Global personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 10 North America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 12 North America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 13 North America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 15 U.S. personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 17 U.S. personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 18 U.S. personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Canada personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 20 Canada personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 21 Canada personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Canada personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 23 Canada personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Mexico personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 25 Mexico personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 26 Mexico personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 27 Mexico personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 28 Mexico personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Europe personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 31 Europe personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 32 Europe personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 33 Europe personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 34 Europe personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 36 Germany personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 37 Germany personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 38 Germany personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 39 Germany personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 41 UK personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 42 UK personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 43 UK personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 44 UK personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 France personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 46 France personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 47 France personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 48 France personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 49 France personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Italy personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 51 Italy personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Italy personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 53 Italy personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 54 Italy personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Spain personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 56 Spain personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 57 Spain personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 58 Spain personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 59 Spain personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Denmark personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 61 Denmark personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 62 Denmark personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 63 Denmark personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 64 Denmark personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Sweden personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 66 Sweden personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 67 Sweden personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 68 Sweden personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 69 Sweden personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Norway personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 71 Norway personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 72 Norway personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 73 Norway personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 74 Norway personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 81 China personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 82 China personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 83 China personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 84 China personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 85 China personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Japan personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 87 Japan personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 88 Japan personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 89 Japan personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 90 Japan personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 91 India personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 92 India personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 93 India personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 94 India personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 95 India personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 97 South Korea personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 98 South Korea personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 99 South Korea personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 100 South Korea personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Australia personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 102 Australia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 103 Australia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 104 Australia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 105 Australia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Thailand personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 107 Thailand personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 108 Thailand personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 109 Thailand personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 110 Thailand personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Latin America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 113 Latin America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 114 Latin America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 115 Latin America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 116 Latin America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Brazil personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 118 Brazil personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 119 Brazil personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 120 Brazil personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 121 Brazil personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Argentina personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 123 Argentina personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 124 Argentina personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 125 Argentina personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 126 Argentina personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 127 MEA personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 129 MEA personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 130 MEA personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 131 MEA personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 132 MEA personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 133 South Africa personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 134 South Africa personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 135 South Africa personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 136 South Africa personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 137 South Africa personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 143 UAE personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 144 UAE personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 145 UAE personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 146 UAE personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 147 UAE personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 149 Kuwait personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 150 Kuwait personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 151 Kuwait personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 152 Kuwait personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Personalized Medicine Outsourcing market: Market outlook
  • Fig. 5 Personalized Medicine Outsourcing market: Segment outlook
  • Fig. 6 Personalized Medicine Outsourcing market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Personalized Medicine Outsourcing market driver impact
  • Fig. 9 Personalized Medicine Outsourcing market restraint impact
  • Fig. 10 Personalized Medicine Outsourcing market: Phase outlook and key takeaways
  • Fig. 11 Personalized Medicine Outsourcing market: Phase movement analysis
  • Fig. 12 Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Phase I market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Phase II market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Phase III market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Phase IV market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Personalized Medicine Outsourcing market: Application outlook and key takeaways
  • Fig. 19 Personalized Medicine Outsourcing market: Application movement analysis
  • Fig. 20 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Rare Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Infectious Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Personalized Medicine Outsourcing market: Service outlook and key takeaways
  • Fig. 25 Personalized Medicine Outsourcing market: Service movement analysis
  • Fig. 26 Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Contact Development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Personalized Medicine Outsourcing market: Type outlook and key takeaways
  • Fig. 29 Personalized Medicine Outsourcing market: Type movement analysis
  • Fig. 30 Inhibitor Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Monoclonal Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cell & Gene Therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others
  • Fig. 34 Personalized Medicine Outsourcing market: End use outlook and key takeaways
  • Fig. 35 Personalized Medicine Outsourcing market: End use movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical Companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Biotechnology Companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Global Laboratory Mixer market: Regional outlook and key takeaways
  • Fig. 40 Global Laboratory Mixer market: Regional movement analysis
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)